Humacyte Inc (HUMA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
3.32 +0.14 (+4.40%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 3.21 -0.11 (-3.31%) 18:59 ET
for Fri, Mar 21st, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Cash Flows From Operating Activities | |||||
Net Income | -110,776 | -11,965 | -26,477 | -66,524 | N/A |
Depreciation Amortization | 8,201 | 9,756 | 9,218 | 8,351 | N/A |
Accounts receivable | 31 | 145 | -63 | 488 | N/A |
Accounts payable and accrued liabilities | 4,811 | -509 | -197 | -889 | N/A |
Other Working Capital | 6,571 | 1,029 | -557 | -2,369 | N/A |
Other Operating Activity | 17,857 | -69,585 | -63,114 | 5,375 | 0 |
Operating Cash Flow | $-73,305 | $-71,129 | $-81,190 | $-55,568 | $N/A |
Cash Flows From Investing Activities | |||||
Change In Deposits | 2,107 | 5,893 | -8,000 | N/A | N/A |
PPE Investments | -2,280 | -1,048 | -220 | -268 | N/A |
Investing Cash Flow | $-173 | $4,845 | $-8,220 | $-268 | $N/A |
Cash Flows From Financing Activities | |||||
Debt Issued | 39,377 | N/A | 29,659 | N/A | N/A |
Debt Repayment | -33,756 | -1,981 | -1,729 | -1,500 | N/A |
Common Stock Issued | 566 | 535 | 598 | 301 | N/A |
Other Financing Activity | -1,680 | 0 | 238,455 | 3,251 | 0 |
Financing Cash Flow | $4,507 | $-1,446 | $266,983 | $2,052 | $N/A |
Beginning Cash Position | 149,772 | 217,502 | 39,929 | 93,713 | N/A |
End Cash Position | 80,801 | 149,772 | 217,502 | 39,929 | N/A |
Net Cash Flow | $-68,971 | $-67,730 | $177,573 | $-53,784 | $N/A |
Free Cash Flow | |||||
Operating Cash Flow | -73,305 | -71,129 | -81,190 | -55,568 | N/A |
Capital Expenditure | -2,280 | -1,048 | -220 | -318 | N/A |
Free Cash Flow | -75,585 | -72,177 | -81,410 | -55,886 | 0 |